The median OS was 81.6 months in the chemoradiotherapy plus surgery group vs. 21.1 months for surgery alone [62]. At 120 months of follow-up, the intervention group had a 38% survival compared with 25% in the control group. When further stratified by pathologic subtype, those with SCC (...